Ruthenium half-sandwich complexes bound to protein kinase Pim-1

Ruthenium half-sandwich complexes bound to protein kinase Pim-1

Pokaži ostale verzije (1)

Bibliografski detalji
Glavni autori:	Debreczeni, J, Bullock, A, Atilla, G, Williams, D, Bregman, H, Knapp, S, Meggers, E
Format:	Journal article
Jezik:	English
Izdano:	Wiley 2006
Teme:	chemistry Proto-Oncogene Proteins c-pim-1 Models, Molecular Protein Kinase Inhibitors Stereoisomerism Protein Structure, Tertiary metabolism Crystallography, X-Ray Ruthenium

Slični predmeti

Ruthenium half-sandwich complexes bound to protein kinase Pim-1.
od: Debreczeni, J, i dr.
Izdano: (2006)

Structure and substrate specificity of the Pim-1 kinase
od: Bullock, A, i dr.
Izdano: (2005)

Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation.
od: Filippakopoulos, P, i dr.
Izdano: (2008)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
od: López-Ramos, M, i dr.
Izdano: (2010)

Crystal Structure-Guided Design of Bisubstrate Inhibitors and Photoluminescent Probes for Protein Kinases of the PIM Family
od: Olivier E. Nonga, i dr.
Izdano: (2021-07-01)

CBL proteins /
od: Tsygankov, Alexander
Izdano: (c200)

Prognostic factors and expression of MDM2 in patients with primary extremity liposarcoma
od: Rosalvo Zósimo Bispo Júnior, i dr.
Izdano: (2008-01-01)

Unraveling the Interplay of KRAS, NRAS, BRAF, and Micro-Satellite Instability in Non-Metastatic Colon Cancer: A Systematic Review
od: Elena Orlandi, i dr.
Izdano: (2024-05-01)

Targeting Pim kinases in hematological cancers: molecular and clinical review
od: Marcia Bellon, i dr.
Izdano: (2023-01-01)

Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia Proliferação celular e apoptose em câncer gástrico e metaplasia intestinal
od: Nora Manoukian Forones, i dr.
Izdano: (2005-03-01)

Immune check point inhibitors in BRAF mutated metastatic colorectal cancer: A review
od: Alfredo Colombo, i dr.
Izdano: (2024-07-01)

Mouse Models as a Tool for Understanding Progression in Braf-Driven Thyroid Cancers
od: Iñigo Landa, i dr.
Izdano: (2019-02-01)

Genetic Aberrations of the K-ras Proto-oncogene in Bladder Cancer in Kashmiri Population
od: Mahoor S. Nanda, i dr.
Izdano: (2010-09-01)

Excellent treatment outcomes in children younger than 18 months with stage 4 nonamplified neuroblastoma
od: Chiwoo Kim, i dr.
Izdano: (2018-02-01)

Histopathologic classification and immunohistochemical features of papillary renal neoplasm with potential therapeutic targets
od: Jeong Hwan Park, i dr.
Izdano: (2024-11-01)

Recent advances and perspectives in ruthenium-catalyzed cyanation reactions
od: Thaipparambil Aneeja, i dr.
Izdano: (2022-01-01)

Oncogene proteins.
od: Malloy, Artur H., i dr.
Izdano: (c200)

The current understanding of KRAS protein structure and dynamics
od: Tatu Pantsar
Izdano: (2020-01-01)

A PIM-1 Kinase Inhibitor Docking Optimization Study Based on Logistic Regression Models and Interaction Analysis
od: George Nicolae Daniel Ion, i dr.
Izdano: (2023-07-01)

Correlation of histopathological patterns in cutaneous melanoma with BRAF mutations Correlação de padrões histopatológicos de melanomas cutâneos com mutações BRAF
od: Juliana Elizabeth Jung, i dr.
Izdano: (2010-12-01)

BRAF V600E Mutation in Odontogenic Keratocyst: A Systematic Review and Meta-Analysis
od: Jéssica da Silva Cunha, i dr.
Izdano: (2025-01-01)

Intrathecal Amylin and Salmon Calcitonin Affect Formalin Induced c-Fos Expression in the Spinal Cord of Rats
od: Zahra Khoshdel, i dr.
Izdano: (2014-11-01)

Mixed pleomorphic xanthoastrocytoma and ganglioglioma with existence of BRAF V600E mutation
od: Lei-ming WANG, i dr.
Izdano: (2017-03-01)

No detection of c-kit gene mutations in exons 9, 11, 13 and 17 and low CD117 expression in plaque-stage mycosis fungoides
od: David Aldo De Luca, i dr.
Izdano: (2018-12-01)

Dasatinib targets c-Src kinase in cardiotoxicity
od: Manar Elmadani, i dr.
Izdano: (2023-01-01)

Notch: From fly wings to human hematological tumors
od: Mirandola Leonardo, i dr.
Izdano: (2009-01-01)

Risk factors analysis for BRAF gene V600E mutation in patients with infiltrative follicular papillary thyroid carcinoma
od: LI Lei, ZHAN Jiezhi, LI Hui, WANG Ruiqing, ZHAO Cheng
Izdano: (2024-08-01)

Noninvasive prediction of BRAF V600E mutation status of pleomorphic xanthoastrocytomas with MRI morphologic features and diffusion-weighted imaging
od: Jing Yan, i dr.
Izdano: (2024-08-01)

The association of BRAF V600E gene mutation with proliferative activity and histopathological characteristics of congenital melanocytic nevi in children
od: Jianyou Chen, i dr.
Izdano: (2023-08-01)

BRAFV600E Mutation Enhances Estrogen-Induced Metastatic Potential of Thyroid Cancer by Regulating the Expression of Estrogen Receptors
od: Minjun Kim, i dr.
Izdano: (2022-12-01)

Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al.
od: Eda Tanrıkulu Şimşek, i dr.
Izdano: (2022-06-01)

PIM1 kinase and its diverse substrate in solid tumors
od: Rituparna Choudhury, i dr.
Izdano: (2024-11-01)

Mutation Profile of Well-Differentiated Thyroid Cancer in Asians
od: Young Shin Song, i dr.
Izdano: (2015-09-01)

Oncogene proteins.
od: Murphy, Peter B., i dr.
Izdano: (c200)

Targeting PIM Kinases to Improve the Efficacy of Immunotherapy
od: Amber N. Clements, i dr.
Izdano: (2022-11-01)

Practical protein crystallography /
od: 196039 McRee, Duncan E., i dr.
Izdano: (1999)

PIM1 signaling in immunoinflammatory diseases: an emerging therapeutic target
od: Xue Yang, i dr.
Izdano: (2024-09-01)

Development of an open-source software for isomer enumeration
od: Salomé R. Rieder, i dr.
Izdano: (2023-01-01)

Mast cells in oral lichen planus and oral lichenoid lesions related to dental amalgam contact
od: Mariana Saturnino de NORONHA, i dr.
Izdano: (2024-01-01)

The FnBPA from methicillin-resistant Staphylococcus aureus promoted development of oral squamous cell carcinoma
od: Li-Xin Kong, i dr.
Izdano: (2022-12-01)